FR1579473A - - Google Patents

Info

Publication number
FR1579473A
FR1579473A FR1579473DA FR1579473A FR 1579473 A FR1579473 A FR 1579473A FR 1579473D A FR1579473D A FR 1579473DA FR 1579473 A FR1579473 A FR 1579473A
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR1579473A publication Critical patent/FR1579473A/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/42Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR1579473D 1966-10-21 1967-10-20 Expired FR1579473A (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58833866A 1966-10-21 1966-10-21

Publications (1)

Publication Number Publication Date
FR1579473A true FR1579473A (tr) 1969-08-29

Family

ID=24353436

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1579473D Expired FR1579473A (tr) 1966-10-21 1967-10-20

Country Status (5)

Country Link
BR (1) BR6794063D0 (tr)
CH (1) CH513136A (tr)
DE (1) DE1668420B2 (tr)
FR (1) FR1579473A (tr)
GB (1) GB1198301A (tr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092037A1 (tr) * 1970-04-13 1972-01-21 Minnesota Mining & Mfg
FR2092036A1 (tr) * 1970-04-13 1972-01-21 Minnesota Mining & Mfg
US3972926A (en) * 1971-01-04 1976-08-03 Riker Laboratories, Inc. Substituted trifluoromethanesulfonanilides
US3981914A (en) * 1971-08-03 1976-09-21 Minnesota Mining And Manufacturing Company N-alkylsulfonylperfluoroalkanesulfonanilides
US3996277A (en) 1974-11-14 1976-12-07 Minnesota Mining And Manufacturing Company 4-Methylthio-2-trifluoromethylmethanesulfonanilide and derivatives thereof
US4005141A (en) 1972-07-03 1977-01-25 Minnesota Mining And Manufacturing Company Perfluoroalkylsulfonamidoaryl compounds
EP0072253A2 (en) * 1981-08-10 1983-02-16 Sumitomo Chemical Company, Limited Trifluoromethanesulfonanilides, and their production and use
EP0368429A2 (de) * 1988-10-07 1990-05-16 Schering Aktiengesellschaft Fluorsubstituierte Benzolderivate
WO2000002850A2 (de) * 1998-07-08 2000-01-20 Aventis Pharma Deutschland Gmbh Sulfonylamino-carbonsäure-n-arylamide als guanylatcyclase-aktivatoren
WO2007116314A1 (en) * 2006-04-10 2007-10-18 Schering-Plough Ltd. N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1745041E (pt) * 2004-04-30 2012-09-24 Genentech Inc Inibidores de quinoxalina da via de sinalização de hedgehog
AU2012200933B2 (en) * 2005-06-22 2015-04-30 Plexxikon, Inc. Pyrrolo [2, 3-B] pyridine derivatives as protein kinase inhibitors
PL1893612T3 (pl) * 2005-06-22 2012-01-31 Plexxikon Inc Pochodne pirolo-[2,3-b]pirydyny jako inhibitory kinazy białkowej
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US20100190777A1 (en) 2007-07-17 2010-07-29 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
WO2010114928A2 (en) 2009-04-03 2010-10-07 F.Hoffmann-La Roche Ag Compositions and uses thereof
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
ES2633317T3 (es) 2009-11-06 2017-09-20 Plexxikon, Inc. Compuestos y métodos para la modulación de quinasas, e indicaciones para ello
AU2012214762B2 (en) 2011-02-07 2015-08-13 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
AR085279A1 (es) 2011-02-21 2013-09-18 Plexxikon Inc Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
EP3760615A4 (en) * 2018-02-27 2021-07-14 Nippon Soda Co., Ltd. HETEROARYL SULFONAMIDE COMPOUND AND PEST CONTROL AGENT

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092037A1 (tr) * 1970-04-13 1972-01-21 Minnesota Mining & Mfg
FR2092036A1 (tr) * 1970-04-13 1972-01-21 Minnesota Mining & Mfg
US3972926A (en) * 1971-01-04 1976-08-03 Riker Laboratories, Inc. Substituted trifluoromethanesulfonanilides
US3981914A (en) * 1971-08-03 1976-09-21 Minnesota Mining And Manufacturing Company N-alkylsulfonylperfluoroalkanesulfonanilides
US4005141A (en) 1972-07-03 1977-01-25 Minnesota Mining And Manufacturing Company Perfluoroalkylsulfonamidoaryl compounds
US3996277A (en) 1974-11-14 1976-12-07 Minnesota Mining And Manufacturing Company 4-Methylthio-2-trifluoromethylmethanesulfonanilide and derivatives thereof
EP0072253A2 (en) * 1981-08-10 1983-02-16 Sumitomo Chemical Company, Limited Trifluoromethanesulfonanilides, and their production and use
EP0072253A3 (en) * 1981-08-10 1983-05-11 Sumitomo Chemical Company, Limited Trifluoromethanesulfonanilides, and their production and use
EP0368429A2 (de) * 1988-10-07 1990-05-16 Schering Aktiengesellschaft Fluorsubstituierte Benzolderivate
EP0368429A3 (en) * 1988-10-07 1990-09-19 Schering Aktiengesellschaft Berlin Und Bergkamen Fluor-substituted benzene derivatives
US5130119A (en) * 1988-10-07 1992-07-14 Schering Aktiengesellschaft Method of using fluorosubstituted benzene derivatives in f-nmr imaging
EP0579261A1 (de) * 1988-10-07 1994-01-19 Schering Aktiengesellschaft Fluorsubstituierte Benzolderivate
WO2000002850A2 (de) * 1998-07-08 2000-01-20 Aventis Pharma Deutschland Gmbh Sulfonylamino-carbonsäure-n-arylamide als guanylatcyclase-aktivatoren
WO2000002850A3 (de) * 1998-07-08 2000-04-13 Aventis Pharma Gmbh Sulfonylamino-carbonsäure-n-arylamide als guanylatcyclase-aktivatoren
US6548547B1 (en) 1998-07-08 2003-04-15 Aventis Pharma Deutschland Gmbh Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators
US6809089B2 (en) 1998-07-08 2004-10-26 Aventis Pharma Deutschland Gmbh Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
US7351703B2 (en) 1998-07-08 2008-04-01 Sanofi-Aventis Deutschland Gmbh Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators
WO2007116314A1 (en) * 2006-04-10 2007-10-18 Schering-Plough Ltd. N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites

Also Published As

Publication number Publication date
DE1668420B2 (de) 1976-11-25
CH513136A (de) 1971-09-30
BR6794063D0 (pt) 1973-09-18
DE1668420A1 (de) 1970-06-25
GB1198301A (en) 1970-07-08

Similar Documents

Publication Publication Date Title
FR1579473A (tr)
AT281852B (tr)
AU428063B2 (tr)
AU424443B2 (tr)
AU414526B2 (tr)
AU415165B1 (tr)
AU417216B2 (tr)
AU421822B2 (tr)
AU1111066A (tr)
AU218666A (tr)
AU1144366A (tr)
BE692110A (tr)
BE675084A (tr)
AU415780B2 (tr)
AU411645B2 (tr)
AU407778B2 (tr)
AU2390066A (tr)
BE694321A (tr)
BE693950A (tr)
BE693394A (tr)
BE654686A (tr)
AU1027866A (tr)
BE691181A (tr)
BE689014A (tr)
BE687686A (tr)